Apollo Hospitals Enterprise Ltd.

NSE: APOLLOHOSP · Healthcare

₹8,446.00+0.90%06 Nov 2026

Ask the data

Instant answers about Apollo Hospitals Enterprise Ltd. — computed from its filings, no language model

Market cap₹1,21,453 cr

Current price₹8,446.00

High / Low₹9,069 / ₹6,794

P/E54.2

P/B11.45

Book value₹737.4

ROE21.1%

ROCE21.7%

Debt / equity0.53

Dividend yield0.24%

EPS (TTM)₹155.92

Face value₹5

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 7 periods

	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	11,247	10,560	14,663	16,612	19,059	21,794	25,228
EBITDA	1,587	1,137	2,185	2,050	2,391	3,022	3,769
Operating margin	14.1%	10.8%	14.9%	12.3%	12.5%	13.9%	14.9%
Interest	533	449	379	381	449	458	450
Depreciation	620	573	601	615	687	758	876
Profit before tax	660	221	1,578	1,144	1,362	2,006	2,616
Tax	225	85	477	256	446	534	658
Net profit	455	150	1,056	819	899	1,446	1,942
EPS ₹	32.70	10.74	73.42	56.97	62.50	100.56	135.04
Operating cash flow	—	—	1,616	1,377	1,920	2,136	2,856
Capex	—	—	657	1,129	1,137	1,713	1,962
Dividend paid	—	—	43	258	221	278	293
Total assets	11,338	11,417	13,192	14,428	16,753	20,657	22,197
Equity	3,339	4,602	5,623	6,197	6,935	8,212	9,480

Quarterly performance

last 29 quarters · ₹ crore

showing latest 8 of 29 periods

	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	2,841	2,912	2,922	2,172	2,761	2,760	2,868	3,760	3,717	3,639	3,546	3,796	4,251	4,264	4,302	4,418	4,847	4,851	4,944	5,086	5,589	5,527	5,592	5,842	6,304	6,477	6,606	7,044	7,615
Operating profit	413	430	380	35	300	390	412	520	615	587	463	491	565	505	488	509	628	614	640	675	816	762	770	852	941	965	1,011	1,092	1,191
Operating margin	14.6%	14.8%	13.0%	1.6%	10.9%	14.1%	14.4%	13.8%	16.5%	16.1%	13.1%	12.9%	13.3%	11.9%	11.3%	11.5%	12.9%	12.7%	13.0%	13.3%	14.6%	13.8%	13.8%	14.6%	14.9%	14.9%	15.3%	15.5%	15.6%
Other income	4	10	4	8	11	6	20	25	6	17	31	16	23	35	16	28	22	28	28	37	38	64	61	40	55	53	44	49	45
Interest	134	137	135	127	122	101	99	95	95	94	95	93	93	100	95	106	111	113	119	116	118	110	115	108	110	113	119	120	114
Depreciation	155	157	164	160	149	125	138	141	145	149	166	148	155	153	159	167	163	167	190	177	184	185	211	215	218	219	224	235	230
Profit before tax	128	145	283	-244	75	170	220	603	380	362	233	266	340	287	250	264	377	362	360	418	552	531	505	569	668	667	711	785	891
Tax	51	55	74	-41	7	51	68	99	116	124	139	-70	114	104	108	97	130	109	110	114	162	157	101	142	181	166	170	188	245
Net profit	86	92	219	-208	60	130	168	489	249	228	90	317	204	153	145	167	233	245	254	305	379	372	390	433	477	502	529	581	630
EPS ₹	6.20	6.62	15.77	-14.97	4.33	9.38	11.77	34.03	17.24	15.88	6.27	22.05	14.19	10.67	10.05	11.59	16.20	17.06	17.65	21.23	26.34	25.89	27.10	30.10	33.19	34.94	36.82	40.39	43.82
Revenue YoY	—	—	—	—	-2.8%	-5.2%	-1.9%	73.2%	34.6%	31.9%	23.7%	0.9%	14.4%	17.2%	21.3%	16.4%	14.0%	13.8%	14.9%	15.1%	15.3%	13.9%	13.1%	14.9%	12.8%	17.2%	18.1%	20.6%	20.8%
Profit YoY	—	—	—	—	-30.1%	41.6%	-23.5%	—	312.7%	75.1%	-46.3%	-35.2%	-18.0%	-32.8%	60.3%	-47.5%	14.2%	59.8%	75.6%	83.2%	62.6%	51.8%	53.5%	41.8%	26.0%	34.9%	35.9%	34.2%	32.0%

Earlier results (standalone, Sep '07 – Jun '19)

₹ crore · from BSE, before the NSE XBRL filings begin

Apollo Hospitals Enterprise Ltd. reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 11 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†	FY18†	FY19†
Revenue	1,458	1,826	2,332	2,800	3,318	3,862	4,593	5,409	6,442	7,295	8,337
Operating profit	220	281	377	464	554	614	678	741	773	830	1,018
Operating margin	15.1%	15.4%	16.2%	16.6%	16.7%	15.9%	14.8%	13.7%	12.0%	11.4%	12.2%
Other income	22	33	21	28	31	22	45	69	27	13	12
Interest	22	38	59	64	73	87	83	134	200	240	268
Depreciation	44	54	70	91	109	129	158	198	241	272	300
Profit before tax	176	222	269	338	403	420	467	452	359	330	462
Tax	58	70	88	107	94	89	121	83	74	97	160
Net profit	118	152	182	231	309	331	347	369	285	233	303

Quarters

showing latest 8 of 48 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†	MAR '18†	JUN '18†	SEP '18†	DEC '18†	MAR '19†	JUN '19†
Revenue	281	289	304	329	365	373	391	406	456	481	483	523	586	601	621	641	700	715	745	777	836	856	848	895	975	993	998	1,054	1,153	1,183	1,204	1,265	1,367	1,381	1,396	1,465	1,634	1,681	1,662	1,684	1,852	1,896	1,863	1,910	2,090	2,169	2,167	2,229
Operating profit	49	43	39	54	57	55	54	68	73	78	63	88	100	94	95	106	120	118	120	130	144	146	133	146	160	158	150	156	173	175	174	181	193	183	184	187	222	194	170	174	221	221	214	227	258	268	266	326
Operating margin	17.4%	15.0%	12.9%	16.4%	15.6%	14.8%	13.7%	16.7%	16.0%	16.2%	13.0%	16.9%	17.0%	15.7%	15.2%	16.5%	17.1%	16.6%	16.1%	16.8%	17.2%	17.1%	15.7%	16.3%	16.4%	15.9%	15.0%	14.8%	15.0%	14.8%	14.5%	14.3%	14.1%	13.2%	13.2%	12.8%	13.6%	11.5%	10.2%	10.3%	11.9%	11.7%	11.5%	11.9%	12.3%	12.3%	12.3%	14.6%
Other income	1	8	8	4	5	8	6	15	2	11	6	4	7	5	6	5	7	10	6	4	14	8	5	6	5	4	7	6	8	26	5	4	4	55	5	5	9	3	9	-4	3	8	6	2	-0	8	2	5
Interest	5	6	5	4	7	7	5	8	10	8	11	16	14	13	16	15	21	13	15	14	19	19	21	20	23	23	21	19	20	22	23	27	31	32	44	44	47	51	58	55	59	64	62	62	66	69	71	100
Depreciation	9	9	10	10	11	11	12	13	13	14	14	16	18	18	18	20	23	24	24	25	27	28	29	31	32	34	33	40	39	39	41	45	46	50	57	56	60	62	63	65	66	68	73	72	74	77	77	110
Profit before tax	36	36	32	44	45	45	42	61	52	66	43	60	75	68	67	76	83	92	87	96	113	108	88	101	111	105	103	104	122	125	117	113	121	130	88	92	124	84	59	50	99	98	84	94	118	130	120	121
Tax	12	10	10	15	15	16	12	16	18	22	14	21	25	22	19	25	27	27	28	26	29	27	12	22	24	22	22	21	30	30	39	23	27	20	13	20	32	11	10	15	28	30	24	34	39	43	43	42
Net profit	24	26	22	29	30	30	29	45	34	44	29	39	50	46	47	51	56	65	59	70	83	81	76	79	87	83	81	83	92	95	77	91	94	109	76	72	92	73	48	35	71	67	60	60	79	87	77	79
EPS ₹	4.57	4.64	3.74	4.99	5.08	4.90	4.84	7.28	5.51	7.10	4.73	6.36	4.01	3.70	3.78	4.11	4.29	4.89	4.41	5.17	6.02	5.80	5.43	5.67	6.25	6.00	5.85	5.95	6.58	6.83	5.56	6.53	6.73	7.85	5.44	5.19	6.61	5.23	3.46	2.53	5.10	4.85	4.29	4.32	5.68	6.25	5.51	5.70
Revenue YoY	—	—	—	—	29.9%	29.0%	28.6%	23.4%	25.0%	28.9%	23.5%	28.9%	28.6%	25.0%	28.7%	22.5%	19.3%	19.0%	19.8%	21.3%	19.5%	19.7%	13.9%	15.1%	16.6%	16.1%	17.7%	17.7%	18.2%	19.0%	20.6%	20.0%	18.6%	16.7%	16.0%	15.8%	19.5%	21.7%	19.0%	14.9%	13.3%	12.8%	12.1%	13.4%	12.9%	14.4%	16.3%	16.7%
Profit YoY	—	—	—	—	27.7%	12.3%	33.1%	53.1%	13.0%	48.7%	0.2%	-12.3%	45.5%	4.3%	61.3%	30.5%	12.5%	41.1%	26.0%	36.1%	49.3%	24.7%	27.3%	13.2%	4.5%	3.5%	7.7%	4.8%	5.2%	13.9%	-4.9%	9.8%	2.4%	15.0%	-2.1%	-20.6%	-1.8%	-33.3%	-36.4%	-51.2%	-22.9%	-7.4%	23.8%	70.9%	11.4%	28.9%	28.6%	31.8%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 26 periods

	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	5.7%	4.9%	6.0%	3.3%	18.4%	22.5%	24.6%	18.8%	15.7%	14.0%	12.8%	13.2%	10.8%	10.7%	12.1%	13.0%	15.0%	15.8%	17.5%	17.6%	19.2%	18.4%	19.8%	20.5%	22.0%	21.1%
ROCE	12.7%	11.7%	11.5%	9.0%	19.9%	23.6%	26.1%	23.7%	19.6%	18.4%	17.6%	17.1%	17.2%	16.7%	17.6%	17.9%	19.6%	17.5%	18.8%	18.3%	19.3%	18.8%	19.8%	20.3%	21.8%	21.7%
Net margin	1.7%	1.5%	1.9%	1.4%	7.0%	7.9%	8.1%	7.2%	6.0%	5.5%	4.8%	4.9%	3.9%	3.9%	4.3%	4.7%	5.3%	5.8%	6.2%	6.6%	7.0%	7.2%	7.4%	7.7%	7.9%	8.1%
EBITDA margin	11.6%	10.6%	10.4%	10.8%	13.3%	14.8%	15.3%	14.9%	14.7%	13.8%	12.8%	12.3%	12.0%	11.9%	12.2%	12.5%	13.0%	13.4%	13.7%	13.9%	14.2%	14.3%	14.6%	14.9%	15.2%	15.4%
Debt / equity	1.00	1.00	1.00	0.62	0.62	0.62	0.62	0.47	0.47	0.43	0.43	0.44	0.44	0.46	0.46	0.46	0.46	0.65	0.65	0.64	0.64	0.59	0.59	0.60	0.60	0.53
Interest coverage	1.58	1.50	1.58	1.49	3.57	4.53	5.10	5.17	4.29	4.21	3.96	4.00	3.90	3.85	3.94	4.03	4.30	4.63	5.02	5.38	5.79	6.14	6.41	6.82	7.13	7.56
Asset turnover	0.96	0.95	0.94	0.92	1.06	1.15	1.22	1.11	1.11	1.09	1.13	1.15	1.19	1.15	1.18	1.14	1.18	1.05	1.08	1.06	1.09	1.06	1.10	1.14	1.19	1.15

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 14 periods

	MAR '18‡	MAR '19‡	MAR '20‡	MAR '21‡	MAR '22‡	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	70	70	70	72	72	72	72	72	72	72	72	72	72	72
Other equity / reserves	3,182	3,264	3,270	4,531	5,551	5,921	6,125	6,437	6,864	7,429	8,140	9,021	9,408	10,532
Total equity	3,252	3,334	3,339	4,602	5,623	5,993	6,197	6,509	6,935	7,501	8,212	9,093	9,480	10,604
Borrowings	2,924	3,450	3,350	2,859	2,636	2,560	2,710	3,010	3,162	4,848	5,275	5,341	5,658	5,595
Current liabilities	1,567	1,955	2,337	2,038	2,383	2,963	3,325	3,780	4,664	5,001	4,579	4,764	6,481	6,920
Non-current liabilities	3,662	3,759	5,531	4,576	4,931	4,720	4,572	4,904	4,768	6,632	7,426	7,633	5,741	5,440
Total assets	8,613	9,183	11,338	11,417	13,192	13,975	14,428	15,561	16,753	19,548	20,657	21,950	22,197	24,222
Property, plant & equipment	4,379	4,594	5,404	5,350	6,162	7,209	7,432	7,771	8,540	9,043	9,816	9,965	11,039	11,003
Capital work-in-progress	712	822	209	212	44	548	602	727	845	1,042	771	1,026	992	1,494
Investments	58	69	75	998	501	631	574	853	986	1,012	2,487	3,008	2,179	2,192
Inventories	566	585	738	250	432	436	390	423	460	448	481	505	542	623
Receivables	825	1,023	1,027	1,331	1,768	2,087	2,234	2,455	2,515	2,880	3,016	3,465	3,485	4,256
Cash & equivalents	306	286	381	425	583	562	433	472	506	1,435	578	488	811	587

Cash flow

annual · ₹ crore · line = free cash flow

showing latest 5 of 9 periods

	FY18‡	FY19‡	FY20‡	FY21‡	FY22	FY23	FY24	FY25	FY26
Cash from operations	537	905	1,293	1,265	1,616	1,377	1,920	2,136	2,856
Cash from investing	-405	-711	-289	-863	-791	-857	-1,537	-3,381	-2,148
Cash from financing	-108	-215	-910	-340	-768	-633	-311	1,317	-478
Capex	621	679	513	296	657	1,129	1,137	1,713	1,962
Free cash flow	-84	226	780	969	958	249	784	424	894
Dividends paid	—	84	155	38	43	258	221	278	293

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹11,003 cr45%

CWIP

₹1,494 cr6%

Investments

₹2,192 cr9%

Inventories

₹623 cr3%

Receivables

₹4,256 cr18%

Cash & equivalents

₹587 cr2%

Other assets

₹4,066 cr17%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%

StoxGud checklist: Bullish setup · 8/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+6.7%

6 months+7.8%

1 year+7.5%

3Y CAGR+17.8%

5Y CAGR+13.9%

10Y CAGR+20.8%

50-day avg₹8,401.71

200-day avg₹8,125.44

RSI (14)66

Long-term financials (FY14–FY15)

from published annual reports

Year	Revenue	Profit before tax	Net profit
FY15	₹299 Cr	₹21 Cr	₹13 Cr
FY14	₹266 Cr	₹12 Cr	₹5 Cr

Years before FY17 follow the older Indian GAAP standard, so they are not exactly comparable with recent years.

Compare Apollo Hospitals Enterprise Ltd. with

Sun Pharmaceutical Industries vs Apollo Hospitals Enterprise Divi's Laboratories vs Apollo Hospitals Enterprise Torrent Pharmaceuticals vs Apollo Hospitals Enterprise Laurus Labs vs Apollo Hospitals Enterprise Apollo Hospitals Enterprise vs Zydus Lifesciences Apollo Hospitals Enterprise vs Dr. Reddy's Laboratories Apollo Hospitals Enterprise vs Cipla

FAQs

What is the share price of Apollo Hospitals Enterprise Ltd.?

Apollo Hospitals Enterprise Ltd. (APOLLOHOSP) closed at ₹8,446.00 on NSE on 06 Nov 2026.

What is the market cap of Apollo Hospitals Enterprise Ltd.?

₹1,21,453 crore at the latest close.

What is the P/E ratio of Apollo Hospitals Enterprise Ltd.?

54.2, on trailing-twelve-month earnings from its filings.

How fast is Apollo Hospitals Enterprise Ltd. growing?

Apollo Hospitals Enterprise Ltd.: revenue has compounded at 14.9% a year over three years; net profit at 33.3% a year. Latest-quarter revenue is up 20.8% year on year, profit up 32.0%.

How profitable is Apollo Hospitals Enterprise Ltd.?

On a trailing-twelve-month basis return on equity is 21.1%, return on capital employed 21.7%, operating margin 15.4%, net margin 8.1%.

How much debt does Apollo Hospitals Enterprise Ltd. have?

Apollo Hospitals Enterprise Ltd. is moderately geared: debt to equity is 0.53 with borrowings of ₹5,595 cr against cash of ₹587 cr (balance sheet of 2026-09-30). Operating profit covers interest 7.6 times.

Financials parsed from Apollo Hospitals Enterprise Ltd.'s own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from SEP '19, annual from FY20, balance sheet from Mar '18. * = derived (full year or half year minus earlier quarters). ‡ = balance sheet / cash flow read from the company's published annual report (same basis), for years before the NSE filings carry them; each one checked to add up. Information only, not investment advice.